Neurolipon (Thioctic Acid)

Thioctic acid functions as a powerful antioxidant that neutralises free radicals, regenerates other antioxidants like vitamins C and E, and chelates metal ions. By lowering oxidative stress, it helps protect neuronal membranes and supports mitochondrial energy production, which can aid peripheral nerve function.

The appropriate dose of Neurolipon is determined by the prescribing healthcare professional based on the patient’s condition, age, renal function and other factors. Patients should follow the dosage instructions provided by their prescriber and not adjust the dose on their own.

Safety data for thioctic acid in pregnancy and lactation are limited. Women who are pregnant, planning to become pregnant, or breastfeeding should discuss potential risks and benefits with their physician before starting Neurolipon.

To place an order, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details (including any cold‑chain requirements) and necessary import documentation.

Neurolipon’s active ingredient, thioctic acid, offers antioxidant and neuroprotective properties that differ from conventional analgesics or anti‑inflammatory drugs. While pain relievers target symptom relief, thioctic acid addresses oxidative damage, which may complement other therapies but does not replace them.

Neurolipon should be stored at room temperature, below 25 °C, in its original packaging. Protect the product from moisture, direct sunlight and extreme temperatures to maintain stability.

Neurolipon is taken orally, usually with or without food, as directed by the prescriber. The tablet or capsule should be swallowed whole with a glass of water and not crushed or chewed unless specifically advised.

Serious risks, though rare, include severe allergic reactions (anaphylaxis), significant liver enzyme elevations, hypoglycaemia in patients on diabetic medication, and rare blood disorders. Patients should seek immediate medical attention if they experience symptoms such as swelling, difficulty breathing, jaundice, or unexplained bruising.

Neurolipon should be avoided in individuals with known hypersensitivity to thioctic acid or any excipients, in patients with uncontrolled thyroid disease, and in those for whom the prescriber determines the risk outweighs the benefit. Consultation with a healthcare professional is essential before starting therapy.